Daniel Drozd

Articles by Daniel Drozd

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)

ByKathryn Martin,Hope Rugo, MD,Gregory Vidal, MD, PhD,Nina Oestreicher,Deepa Lalla,Gillian Hanson,Daniel Drozd,Kristie Traverso,Dan DiPrimeo,Debu Tripathy, MD

April 18th 2022

Latest Updated Articles

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)
April 18th 2022

Trending on CancerNetwork

FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

Intismeran Plus Pembrolizumab Reduces Recurrence Risk in Resected Melanoma

Which Head and Neck Cancer Data Should You Watch For at ESMO 2026?

Reducing Stigma and Nihilism Around Lung Cancer Screening and Diagnosis

From KEYNOTE-B49 to Novel ADCs: Breast Cancer Trials to Watch at ESMO 2026